enVVeno Medical (NVNO) Other Working Capital Changes (2020 - 2026)

enVVeno Medical's Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$97000.0 for Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 14.12% year-over-year to -$97000.0 in Q1 2026; TTM through Mar 2026 was -$376000.0, a 11.24% decrease from a year earlier, with the FY2025 full-year figure at -$364000.0, down 7.69% from the prior year.
• Other Working Capital Changes retreated to -$97000.0 in Q1 2026 per NVNO's latest filing, from -$91000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $203000.0 in Q3 2024 and bottomed at -$205000.0 in Q1 2024.
• The 5-year median for Other Working Capital Changes is $11000.0 (2022), against an average of $22400.0.
• Across the five-year window, Other Working Capital Changes gained 8.86% in 2022 and retreated 15.48% in 2025, its largest moves.
• Year by year, Other Working Capital Changes stood at -$73000.0 in 2022, then retreated by 6.85% to -$78000.0 in 2023, then dropped by 7.69% to -$84000.0 in 2024, then retreated by 8.33% to -$91000.0 in 2025, then dropped by 6.59% to -$97000.0 in 2026.
• Per Business Quant, the three latest NVNO Other Working Capital Changes figures stand at -$97000.0 (Q1 2026), -$91000.0 (Q4 2025), and -$91000.0 (Q3 2025).